Page last updated: 2024-11-05

1-chloro-2-nitrobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-Chloro-2-nitrobenzene, also known as o-chloronitrobenzene, is a pale yellow to light brown liquid at room temperature. It is a synthetic compound not found naturally. It is synthesized by the nitration of chlorobenzene, which results in a mixture of ortho, meta, and para isomers, with the ortho isomer being the most abundant. 1-Chloro-2-nitrobenzene is primarily used as an intermediate in the production of other organic compounds, including pharmaceuticals, dyes, and pesticides. It is also used as a solvent and a plasticizer. This compound has been researched for its potential biological activity, including antimicrobial and antifungal properties. However, it has also been found to be toxic to aquatic organisms and may cause skin and eye irritation. Therefore, its use and handling require caution. 1-Chloro-2-nitrobenzene is studied to understand its reactivity, its potential uses, and its environmental impact.'

Cross-References

ID SourceID
PubMed CID6945
CHEMBL ID53330
CHEBI ID34270
SCHEMBL ID78743

Synonyms (87)

Synonym
BIDD:ER0655
2-nitrochlorobenzene
nsc36934
nsc-36934
88-73-3
2-chloro-1-nitrobenzene
o-nitrochlorobenzene
2-chloronitrobenzene
chloro-o-nitrobenzene
wln: wnr bg
1-chloro-2-nitrobenzene ,
nitrochlorobenzene, liquid
benzene, 1-chloro-2-nitro-
o-chloronitrobenzene
oncb
MLS001055388
smr000677934
AC-907/25014094
inchi=1/c6h4clno2/c7-5-3-1-2-4-6(5)8(9)10/h1-4
benzene, chloronitro-
nitrochlorobenzene
mononitrochlorobenzene
chloronitrobenzene
einecs 246-695-6
altitran
NCGC00090715-01
ccris 141
ai3-15385
einecs 201-854-9
nsc 36934
hsdb 1322
1-nitro-2-chlorobenzene
GHL.PD_MITSCHER_LEG0.936
1-chloro-2-nitrobenzene, 99%
NCGC00090715-02
chebi:34270 ,
CHEMBL53330
AKOS000118963
NCGC00090715-03
ec 201-854-9
chloronitrobenzene, ortho, liquid [un1578] [poison]
chloronitrobenzene, ortho, liquid
unii-d1yi9r2k8o
d1yi9r2k8o ,
HMS3039K15
cas-88-73-3
tox21_200791
NCGC00258345-01
dtxsid0020280 ,
dtxcid80280
unii-846gsp547v
846gsp547v ,
STL283954
SCHEMBL78743
1-chloro-2-nitrobenzene [hsdb]
chloro-2-nitrobenzene, 1-
o-chloronitrobenzene [mi]
1-chloro-2-nitro-benzene
2-nitro-chlorobenzene
4-chloro-3-nitrobenzene
2-chloro-nitrobenzene
2-nitro chlorobenzene
ortho-nitro-chlorobenzene
o-chloro-nitrobenzene
2-chloro nitrobenzene
ortho-chloronitrobenzene
ortho-nitrochlorobenzene
nitrochlorobenzene, ortho
2-nitro-1-chlorobenzene
nitrochlorobenzene, o-
AM87358
benzene,chloronitro-
J-510174
F1908-0107
mfcd00007061
1-chloro-2-nitrobenzene, analytical standard
1-chloro-2-nitrobenzene, purum, >=99.0% (gc)
D87558
1-chloro-2-nitrobenzene 10 microg/ml in methanol
1-chloro-2-nitrobenzene 100 microg/ml in methanol
Q2803418
1-chloro-2-nitrobenzene;chloro-2-nitrobenzene, 1-;2-chloro-1-nitrobenzene;benzene, 1-chloro-2-nitro-;o-chloronitrobenzene;1-chloro-2-nitrobenzene chloro-2-nitrobenzene, 1- 2-chloro-1-nitrobenzene benzene, 1-chloro-2-nitro- o-chloronitrobenzene
1-chloro,2-nitrobenzene
2-chloronitrobenzene 2-nitrochlorobenzene
BS-42463
EN300-19237
Z104473258

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The two isomers induced hematotoxicity and hepatotoxicity of different toxic potencies."( Thirteen-week oral toxicity of para- and ortho- chloronitrobenzene in rats and mice.
Aiso, S; Arito, H; Matsumoto, M; Matsushima, T; Nagano, K; Umeda, Y; Yamamoto, S, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 micrograms per plate in a modified Ames assay."( Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants.
Connor, TH; Wilkerson, MG; Wilkin, JK, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
1-chloro-2-nitrobenzene degradation46

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency0.89130.707936.904389.1251AID504333
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency49.13400.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency39.02850.023723.228263.5986AID743223
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency0.01880.000627.21521,122.0200AID651741
gemininHomo sapiens (human)Potency20.59620.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1654591Substrate activity at MGST1 in rat liver microsomes assessed as reactivity rate at 50 uM incubated for 1 to 40 mins in presence of GSH by liquid chromatography/mass spectrometry2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
AID310933Permeability across PAMPA membrane after 7 hrs2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID310931Partition coefficient, log P of the compound2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID216482Ability to inhibit expression of Vascular cell adhesion molecule 1; No effect2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Nitrobenzene compounds inhibit expression of VCAM-1.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (11.11)18.7374
1990's7 (15.56)18.2507
2000's13 (28.89)29.6817
2010's16 (35.56)24.3611
2020's4 (8.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.88 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index64.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.17%)6.00%
Case Studies2 (4.17%)4.05%
Observational0 (0.00%)0.25%
Other44 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]